zepbound glp-1 weight-loss drugs: PA, NJ poison control centers see more calls Zepbound Helped Type 1 Diabetes

Important Safety Information for Soliqua 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL What is the most important information I should know about Soliqua 100/33

doi: 10.1021/jm9909645 [DOI] [PubMed] [Google Scholar] 132

In part 2 well look at the case of Juanita Gantt

Eli Lilly reiterated to NPR that the drugs have been "available since August." "Our current manufacturing investment of over $20 billion in the past four years is the most significant in our history, and will allow us to continue increasing capacity to safely bring these medicines to people who need them," Eli Lilly spokesperson Courtney Kasinger wrote in an email

Pittman found that the FDA had taken into account supply and demand data, including public comments from Novo Nordisks CEO regarding limited access to the drugs

Some groups who still plan to cover GLP-1s have imposed hurdles for patients to obtain and stay on the medications